Hepatitis C

Translating Basic Science Into Clinical Application

Dec. 7, 2017

The CMGH editors summarize five recently accepted studies in four sentences or less.

Building Foundations Among Payers & Providers for Collaborative Care in HCV & HIV

Dec. 7, 2017

In this video, leading experts in HCV, HIV, and managed care engage in a crossfire panel discussion on key challenges, considerations and solutions for improving patient management, and appropriate access to HCV and HIV therapies.

Experts Update HCV Treatment and Care Guidelines

Nov. 9, 2017

Revision adds newly approved treatments and recommendations for special populations.

Why the VA is So Successful Tackling HCV

Oct. 26, 2017

VA experts tell how they get high-risk patients engaged, nationally.

Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice

Oct. 22, 2017

Our work indicates that the heterogeneity in buoyant density of infectious HCV particles evolves over the course of infection and can be influenced by diet.

Native Americans Have Highest HCV Rates

Oct. 12, 2017

Treatment for HCV challenging due to the limited Indian Health Services (IHS) funding.

Duration of Hepatitis C Virus Therapy

Oct. 11, 2017

Shorter duration therapy reduces treatment costs and may also improve adherence. How short can therapy be and who would qualify?

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.

Is HCV Drug Development Nearing Its End?

Sept. 28, 2017

Two new FDA approvals fill medical gaps, but access to treatment remains a challenge.

Recently Incarcerated Have High Rates of HCV and Little Help

Sept. 14, 2017

Integrated care in prison systems is key to reducing rates and transmission risk post-release.

Achalasia: It’s Not All About the Lower Esophageal Sphincter

Aug. 24, 2017

A 66-year-old man with cirrhosis secondary to hepatitis C and achalasia presented as a referral for evaluation and management.

Treating HCV in Incarcerated Populations Key to Disease Elimination

Aug. 17, 2017

Infection rates range from 9.6 percent to 41.1 percent. Read more in the AGA-MedPage Today Reading Room.

Risk Factors of Prednisolone May Outweigh Benefit in Treatment of Severe Alcoholic Hepatitis (SAH)

Aug. 17, 2017

Gastroenterology researchers discuss their findings in video abstract.

Previously Cured HCV Patients Can Be Reinfected

Aug. 3, 2017

Prevention will require attention to high-risk behaviors.

Make an Impact on World Hepatitis Day

July 27, 2017

World Hepatitis Day, July 28, is an opportunity to join in on the fight to end viral hepatitis.

Primary Care Providers Can Treat Hep C

July 24, 2017

Primary care physicians and nurse practitioners can achieve cure rates matching those of liver disease specialists.

Latest Issue of AGA Perspectives is Now Available

July 19, 2017

The new issue of AGA Perspectives examines the use of anti-TNF therapy, the promising outlook of stool DNA testing and revisits the gut microbiome of AGA members.

Looking at the Twin Epidemics of HCV

July 6, 2017

Younger cohorts at risk of HCV need more attention.

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

June 26, 2017

We performed an open-label, prospective, multicenter study of the effectiveness and tolerance of an all-oral, interferon- and ribavirin-free regimen of sofosbuvir plus daclatasvir in patients with HCV-associated CryoVas.

New WHO Report: More Work Needed to Diagnose, Treat Viral Hepatitis Worldwide

June 22, 2017

Just 20 percent of people with hepatitis C have been diagnosed, and only 7 percent have been treated.

Member Benefit Spotlight: GastroSlides

June 15, 2017

Free access to AGA's GastroSlides is now a member benefit.

Course for NPs and PAs Benefits All Experience Levels

June 14, 2017

Find out how AGA's popular course, Principles of GI for the NP and PA, benefits all those who attend, regardless of experience level or practice setting.

Canadian HCV Screening Guidelines Do Not Include Baby Boomers

June 8, 2017

Controversial guidelines spark debate.